Mischer Neuroscience Institute

Mischer Neuroscience Institute has multiple firsts:

• The first center to discover a genetic mutation linked to intracranial aneurysms.
• The first stroke program in Texas and the only one in the region to meet The Joint Commission's rigorous standards for Comprehensive Stroke Center certification. In 2018, the Stroke Center at Memorial Hermann-TMC became the first Comprehensive Stroke Center-Integrated System, a new certification created by The Joint Commission specifically for Memorial Hermann.
• Site of the first single-center clinical trial for recurrent medulloblastoma, ependymoma and atypical teratoid-rhabdoid tumors using the direct infusion of chemotherapy into the fourth ventricle; the first trial of infusion of 5-AZA into the fourth ventricle or resection cavity in children with recurrent posterior fossa ependymoma; and the first trial of combination intraventricular chemotherapy (methotrexate and etoposide) infusions into the fourth ventricle or resection cavity in children with recurrent posterior fossa brain tumors.
• The first neurosurgery center to offer all advanced modalities of treatment for complex lesions: expert microsurgery, interventional neuroradiology/endovascular surgery and Gamma Knife® radiosurgery.
• The first hospital in the south-central United States and one of only a few in the country offering intra-arterial chemotherapy for retinoblastoma, the most modern treatment for the disease.
• The first in Texas to use robotic stereoencephalography (SEEG) for 3-D mapping of epileptic seizures.
• The first in Houston to offer amyloid imaging, a diagnostic tool that enables physicians to diagnose Alzheimer's disease.
• The North American leader in studies of primary progressive multiple sclerosis and the most active center in Texas in the conduct of organized clinical trials of new therapies for MS.
• The first facility in Houston and one of the first in the United States to test the clot- dissolving drug tPA for acute stroke.
• One of the first centers in the nation to offer MR-guided laser interstitial thermal therapy (MRgLITT) using the Visualase™ system for the treatment of well-delineated focal epilepsies.
• The first center in the region to use the NeuroPace® RNS® System, an FDA-approved technique for responsive neurostimulation to treat adults with medication-resistant epilepsy.
• The first in the region to inject human central nervous system stem cells into the spines of spinal cord injury patients.

The Mischer Neuroscience Institute is affiliated with McGovern Medical School at UTHealth Houston Neurosciences, offering neurosurgery and neurology residencies and fellowships. These programs provide educational and research opportunities for residents and fellows, focusing on various aspects of neurological medicine within a large medical center.

The Vivian L. Smith Department of Neurosurgery hosts a seven-year Neurosurgery Residency Program, admitting three PGY(Post-Graduate-Year) residents annually. Residents receive individualized mentorship, evaluations, and promotions, actively engaging in program assessment and enhancement. With a significant caseload of over 4,600 surgical cases per year, the program ranks among the United States' largest in terms of neurosurgical volume. Neurosurgical fellowships cover specialized areas including cerebrovascular/skull base, neurocritical care, and neuroendovascular surgery.

The Department of Neurology offers medical education in clinical neurology at the undergraduate, graduate, and postgraduate levels. The Neurology Residency Training Program prepares physicians for independent neurology practice. Additionally, neurological fellowships are available, focusing on clinical neurophysiology (including EEG, EEG/video monitoring, EMG, and evoked potentials), vascular neurology, epilepsy, movement disorders, multiple sclerosis/neurovirology, neuroimmunology, and neuropsychology.

Physicians affiliated with Mischer Neuroscience Institute and McGovern Medical School are engaged in research program focused on the mechanisms, treatment and cure of neurological disease and injury. Research is supported by the National Institutes of Health, the Vivian L. Smith Foundation for Neurologic Disease, the American Stroke Association and other granting agencies. Investigations cover all major areas of neurological disease.

UTHealth Houston Neurosciences medical clinics are located both in the Texas Medical Center and throughout the Greater Houston area. The clinics provide 24/7 neuroscience coverage to the city of Houston and outlying suburbs and communities. Clinics are located in the Texas Medical Center, Houston's Greater Heights, Humble, Katy, Memorial City, Pearland, Southeast Houston, Southwest Houston and Sugar Land. UTHealth Houston Neurosciences also includes clinics that bring together specialists who focus on treating brain tumors, spine disorders, movement disorders, radiation oncology, pain management, epilepsy and seizure disorders, memory disorders, nerve and neuromuscular disorders, and pediatric neurology and neurosurgery.